Supplementary Material for: Evolution of growth following anti-TNF-α therapy in paediatric Crohn’s disease: data from the Swiss IBD Cohort Study by figshare admin karger (2628495)

“…Patients treated with biologics exhibited significant height increase at T1 (p=0.022), with an overall flat height evolution (y=0.00x-0.31), whereas significant weight increase was maintained at T5 (p=0.0005, y=0.13x-0.50). …”

Opportunistic analysis of clinically actionable DPYD gene variants in a germline testing cohort in India by Rajdeep Raha (22056304)

“…</p> <p>A total of 95 individuals (5.3%) carried at least one decreased or no function DPYD variant, indicating a significant prevalence of clinically actionable genotypes in this Indian cohort. …”

Image 3_Age-period-cohort analysis of syphilis epidemics in Eastern China, China, 2005–2024.jpeg by Zheyuan Ding (4281394)

“…The cohort effect shows that the risk decreased in later birth cohorts, with the highest reported incidence risk in the birth cohort of 1960–1964 (RR = 1.30; 95% CI: 1.08, 1.57) and the lowest risk in the birth cohort of 2020–2024 (RR = 0.00; 95% CI: 0.00, 0.18).…”

Image 2_Age-period-cohort analysis of syphilis epidemics in Eastern China, China, 2005–2024.jpeg by Zheyuan Ding (4281394)

“…The cohort effect shows that the risk decreased in later birth cohorts, with the highest reported incidence risk in the birth cohort of 1960–1964 (RR = 1.30; 95% CI: 1.08, 1.57) and the lowest risk in the birth cohort of 2020–2024 (RR = 0.00; 95% CI: 0.00, 0.18).…”

Supplementary Material for: The Effectiveness of a Hospital-Based Antimicrobial Stewardship Program: A Three-Year Observational Study by figshare admin karger (2628495)

“…Resistance rates for VRE and CRE decreased (44% to26% and 47% to42%, respectively) without statistical significance. …”

Supplementary Material for: Off-label Use of Mycophenolate Mofetil in Immunoglobulin A Nephropathy: A Systematic Review and Meta-analysis by Feng L. (5056958)

“…MMF treatment in IgAN was associated with decreasing the occurrence of MAKDE (RR, 0.32; 95%CI, 0.13 to 0.77), reducing proteinuria (RR, 1.41; 95%CI, 1.22 to 1.64), and lessening the probability of doubling blood creatinine (RR, 0.32, 95% CI, 0.14 to 0.72). …”

Supplementary Material for: Anti-Vascular Endothelial Growth Factor Treatment Outcomes in Macular Telangiectasia: A Systematic Review by figshare admin karger (2628495)

“…In non-proliferative MacTel, four studies showed no functional improvement, two reported significant functional and morphological improvements, and one suggested potential benefits in improving BCVA. …”

Additional file 2 of Whole genome sequencing of the pulmonary microbiome in interstitial lung disease subtypes by Kristel S. Knudsen (10535406)

Image 5_Age- and sex-specific reference intervals for trace elements in infants and children: a multi-center study in Lincang, China.jpg by Junqiang Li (491954)

“…After data cleaning, 3933 samples were analyzed for age subgroup partitioning of trace elements from 1 month through 18 years. The difference between the age sub-groups was statistically significant according to the Harris-Boyd method and the Lahti method. …”

Image 3_Age- and sex-specific reference intervals for trace elements in infants and children: a multi-center study in Lincang, China.jpg by Junqiang Li (491954)

“…After data cleaning, 3933 samples were analyzed for age subgroup partitioning of trace elements from 1 month through 18 years. The difference between the age sub-groups was statistically significant according to the Harris-Boyd method and the Lahti method. …”

Image 2_Age- and sex-specific reference intervals for trace elements in infants and children: a multi-center study in Lincang, China.jpg by Junqiang Li (491954)

“…After data cleaning, 3933 samples were analyzed for age subgroup partitioning of trace elements from 1 month through 18 years. The difference between the age sub-groups was statistically significant according to the Harris-Boyd method and the Lahti method. …”

Image 4_Age- and sex-specific reference intervals for trace elements in infants and children: a multi-center study in Lincang, China.jpg by Junqiang Li (491954)

“…After data cleaning, 3933 samples were analyzed for age subgroup partitioning of trace elements from 1 month through 18 years. The difference between the age sub-groups was statistically significant according to the Harris-Boyd method and the Lahti method. …”

Image 6_Age- and sex-specific reference intervals for trace elements in infants and children: a multi-center study in Lincang, China.jpg by Junqiang Li (491954)

“…After data cleaning, 3933 samples were analyzed for age subgroup partitioning of trace elements from 1 month through 18 years. The difference between the age sub-groups was statistically significant according to the Harris-Boyd method and the Lahti method. …”

Differences between patients and controls. by Jolanda Malamud (19727472)

“…The bars indicate the mean and the dots individual subjects. Significance *≤0.5, **≤0.1, ***≤0.001, ****≤0.0001. Black frames survive correction for multiple comparisons.…”

Table 9_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

“…In horses, two multivariable models explained the maximum amount of data variability. Model 1 demonstrated increased odds of seropositivity in mares [odds ratio (OR) = 2.90 95% CI 1.70–4.95, p < 0.001] and decreased odds in horses <2.5 years (OR = 0.46 95% CI 0.22–0.95, p = 0.04; reference: ≥4.5 years). …”

Table 2_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

“…In horses, two multivariable models explained the maximum amount of data variability. Model 1 demonstrated increased odds of seropositivity in mares [odds ratio (OR) = 2.90 95% CI 1.70–4.95, p < 0.001] and decreased odds in horses <2.5 years (OR = 0.46 95% CI 0.22–0.95, p = 0.04; reference: ≥4.5 years). …”

Table 10_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

“…In horses, two multivariable models explained the maximum amount of data variability. Model 1 demonstrated increased odds of seropositivity in mares [odds ratio (OR) = 2.90 95% CI 1.70–4.95, p < 0.001] and decreased odds in horses <2.5 years (OR = 0.46 95% CI 0.22–0.95, p = 0.04; reference: ≥4.5 years). …”

Table 3_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

“…In horses, two multivariable models explained the maximum amount of data variability. Model 1 demonstrated increased odds of seropositivity in mares [odds ratio (OR) = 2.90 95% CI 1.70–4.95, p < 0.001] and decreased odds in horses <2.5 years (OR = 0.46 95% CI 0.22–0.95, p = 0.04; reference: ≥4.5 years). …”

Table 8_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

“…In horses, two multivariable models explained the maximum amount of data variability. Model 1 demonstrated increased odds of seropositivity in mares [odds ratio (OR) = 2.90 95% CI 1.70–4.95, p < 0.001] and decreased odds in horses <2.5 years (OR = 0.46 95% CI 0.22–0.95, p = 0.04; reference: ≥4.5 years). …”

Table 6_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

“…In horses, two multivariable models explained the maximum amount of data variability. Model 1 demonstrated increased odds of seropositivity in mares [odds ratio (OR) = 2.90 95% CI 1.70–4.95, p < 0.001] and decreased odds in horses <2.5 years (OR = 0.46 95% CI 0.22–0.95, p = 0.04; reference: ≥4.5 years). …”